ZNF367 inhibits cancer progression and is targeted by miR-195. Autor Meenu Jain, Lisa Zhang, Myriem Boufraqech, Yi Liu-Chittenden, Kimberly Bussey, Michael J Demeure, Xiaolin Wu, Ling Su, Karel Pacak, Constantine A Stratakis, Electron Kebebew

Získat plný text

The histone variant H2A.X is a regulator of the epithelial–mesenchymal transition Autor Urbain Weyemi, Christophe E. Redon, Rohini Choudhuri, Towqir Aziz, Daisuke Maeda, Myriem Boufraqech, Palak R. Parekh, Taresh K. Sethi, Manjula Kasoji, Natalie Abrams, Anand Merchant, Vinodh N. Rajapakse, William M. Bonner

Získat plný text

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer Autor Dipranjan Laha, Robert R.C. Grant, Prachi Mishra, Myriem Boufraqech, Min Shen, Ya-Qin Zhang, Matthew D. Hall, Martha Quezado, Michelly Sampaio De Melo, Jaydira Del Rivero, Martha Zeiger, Naris Nilubol

Získat plný text